BCAX Bicara Therapeutics

Watchlist

Close Dec 13 16:00 ET

Post 20:01 ET

952.27MMarket Cap-16.01P/E (TTM)

Bicara Therapeutics Key Stats

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

Bicara Therapeutics | 10-Q: Quarterly report

Nov 12 16:09 ET

Bicara Therapeutics | 8-K: Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12 13:44 ET

Updated: Dec 6, 2024

Strong Buy

No Data

Overall

No Data